CN107137682A - A kind of Chinese medicine composition for treating apoplexy and application - Google Patents
A kind of Chinese medicine composition for treating apoplexy and application Download PDFInfo
- Publication number
- CN107137682A CN107137682A CN201710360144.1A CN201710360144A CN107137682A CN 107137682 A CN107137682 A CN 107137682A CN 201710360144 A CN201710360144 A CN 201710360144A CN 107137682 A CN107137682 A CN 107137682A
- Authority
- CN
- China
- Prior art keywords
- medicine
- apoplexy
- parts
- angelicae sinensis
- jute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition for treating apoplexy and its application, described pharmaceutical composition with following raw materials by being made：Jute, gypsum, osmanthus heart, rhizoma zingiberis, Ligusticum wallichii, Radix Angelicae Sinensis, radix scutellariae, almond.The present invention specify that the formula and preparation method of medicine, overcome the deficiency of existing treatment apoplexy medicine, and function admirable, the therapeutic effect of Patients with Apoplexy After is good.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines, and in particular to a kind of important drug composition for treating apoplexy and application.
Background technology
Apoplexy is the common refractory disease for seriously endangering human health and life security, usually brings three inclined symptoms：
Hemiplegia (side myodynamia decline, activity it is unfavorable or completely it is stiff), hemidysesthesia (it is cold and hot do not know, pain not
Feel), hemianopsia (defect of visual field, blurred vision), and with dysphonia or motor aphasia.In a big way or after multiple relapse
Spirit and dysnoesia (personality change, One's spirits are drooping, emotional, dementia) can be left by losing the symptom of disease.Therefore to the pre- of apoplexy
The anti-research with treatment causes the very big concern of people always.
Chinese invention patent 101843851B is related to the preparation of anti-hypertension apoplexy medicine, it is desirable to provide a kind of anti-hypertension
Dendrobium officinale nimodipine combination medicine of apoplexy and preparation method thereof.The dendrobium candidum Nimodipine of the anti-hypertension apoplexy is closed
With medicine, effective component includes the mass ratio of dendrobium officinale aqueous extract and Nimodipine, dendrobium officinale aqueous extract and Nimodipine
For 1.0~4.0: 0.12~0.24.The invention is additionally provided in the medicinal extract based on the medicine, granule, tablet, capsule, medicine
Mesosome and preparation method thereof.The invention, which discloses the use of combination with medication and dendrobium candidum or the independent of Nimodipine any one, to be made
With comparing, not only can be faster reduce blood pressure is better able to the reduction death rate, extension life span.Such as spy
The medicine for determining purposes is used, and can relax lasting reduction hyperpietic's blood pressure, delays hypertensive cerebral vascular infringement progress,
To mankind's preventing hypertension apoplexy, the disabling of reduction high blood pressure, fatal rate are significant.
Chinese invention patent 102614234B discloses a kind of Aggrenox compositions and tablet and preparation method thereof.Side
Method：Crude drug Ligusticum wallichii and Radix Angelicae Sinensis are added into 10 times of 70% ethanol of amount for the first time, extractor is placed in, keeps 70-100 DEG C of extraction 2 small
When, extract solution is filtered out, the first extract solution is obtained, solid filter residue is stand-by.8 times of 70% ethanol of amount are added in solid filter residue, are placed in
Extractor, is kept for 70-100 DEG C extract 1.5 hours, filters out extract solution, filter out extract solution, obtains the second extract solution and solid filter
Slag.Mixed extract, under the conditions of temperature is 60-70 DEG C, no alcohol taste is concentrated under reduced pressure into mixed liquor, obtains extracting concentration
Thing, the relative density of concentrate is 1.10~1.30, and its Midst density is measured at 60 DEG C；Add what is crushed in extraction concentrat
Natural borneol dissolves, and produces Pharmaceutical composition；The weight proportion of medicinal material used is：10~50 parts of Ligusticum wallichii, Radix Angelicae Sinensis 50~10 part, day
Right 1~10 part of borneol.Obtained composition has obvious repair to apoplexy, the impaired of cranial nerve function.
Chinese invention patent 104435318B discloses a kind of extraction for treating hemorrhagic stroke Chinese medical extract components group
Method and its application.Rheum officinale, the root bark of tree peony, the radix paeoniae rubrathe, the dried rhizome of rehmannia, pseudo-ginseng add water to cook extraction, extract solution according to a certain weight ratio, after crushing
After being extracted with dichloromethane, water layer uses extracting n-butyl alcohol again, is Chinese medical extract components group after butanol extraction liquid recovery is dry.Should
Chinese medical extract is analyzed by Chinese herbaceous peony glycoside, tannin class, Paeonol glycoside, Anthraquinones, stilbene class, saponins and cyclenes with HPLC-MS
33 composition compositions of ether terpene glycoside, can significantly reduce male spontaneously hypertensive rat neuronspecific enolase, S-
100 β albumen, IL-1, TNF-α, plasma fibrinogen level, available for the purposes for preparing treatment hemorrhagic stroke medicine.
However, the effect of the medicine of Current therapeutic apoplexy is not good.According to statistics, the annual disease for occurring headstroke of China
People is just up to 2,000,000.Existing survival stroke patient 7,000,000, wherein the different degrees of disability of 4,500,000 patients and life be unable to from
Reason, disability rate is up to 75%.Chinese annual stroke patient dead 1,200,000.
The content of the invention
Goal of the invention：In order to improve the therapeutic effect of stroke patient, the invention provides a kind of Chinese medicine group for treating apoplexy
Compound.
To achieve the above object, by a large amount of practices of inventor, medicine of the invention is made up of following raw materials：
Jute, gypsum, osmanthus heart, rhizoma zingiberis, Ligusticum wallichii, Radix Angelicae Sinensis, radix scutellariae, almond.
Preferably, to being limited below the work by weight ratio of each component：
1 part of Radix Angelicae Sinensis, 1 ~ 1.5 part of radix scutellariae, osmanthus heart, rhizoma zingiberis, 2 ~ 3 parts of Ligusticum wallichii, gypsum, 3 ~ 4 parts of almond, 6 ~ 7 parts of jute.
Further preferably, medicine of the invention is made up by weight of following raw materials according：
Radix Angelicae Sinensis, 1 part of radix scutellariae, osmanthus heart, rhizoma zingiberis, 2 parts of Ligusticum wallichii, gypsum, 3 parts of almond, 6 parts of jute.
The formulation of pharmaceutical composition of the present invention can be the medical science such as decoction, pill, powder, tablet, capsule, granule
Upper acceptable formulation, preparation is processed by existing common process.
Present invention additionally comprises said medicine for treating the application in apoplexy.
The pharmaceutical formulation of the present invention, for the pathogenesis of apoplexy, has the effect of replenishing and activating blood from Radix Angelicae Sinensis；Ligusticum wallichii has
There are promoting qi circulation and relieving pain, warming kidney and enhancing yang, the broken product effect of stagnation resolvation；Rhizoma zingiberis has warming spleen and stomach for dispelling cold, Back to Yang Tongmai, the effect of Wenfei of drink；It is yellow
A kind of reed mentioned in ancient books has the effect of heat-clearing and damp-drying drug, purging intense heat and detonicating, hemostasis, hypotensive；Zhu Fang is shared, and can reach the purpose treated both principal and secondary aspect of disease, right
The symptoms such as miocardial infarction, cerebral infarction, apoplexy, heart rhythm disorders, acute cerebral hemorrhage disease have good curative effect.
Embodiment
The present invention is further illustrated with reference to embodiment.
Radix Angelicae Sinensis, 100 grams of radix scutellariae, osmanthus heart, rhizoma zingiberis, 200 grams of Ligusticum wallichii, gypsum, 300 grams of almond, 600 grams of jute are taken, it is standby；Will
Jute is put into 4 liters of water, is boiled, filtering, is added other all medicinal materials, is boiled, obtain decoction.
Claims (5)
1. a kind of medicine, it is characterised in that the medicine is by jute, gypsum, osmanthus heart, rhizoma zingiberis, Ligusticum wallichii, Radix Angelicae Sinensis, radix scutellariae, almond group
Into.
2. a kind of medicine according to claim 1, it is characterised in that each component of described medicine example in mass ratio is matched
It is as follows：1 part of Radix Angelicae Sinensis, 1 ~ 1.5 part of radix scutellariae, osmanthus heart, rhizoma zingiberis, each 2 ~ 3 parts of Ligusticum wallichii, gypsum, each 3 ~ 4 parts of almond, 6 ~ 7 parts of jute.
3. a kind of medicine according to claim 2, it is characterised in that each component of described medicine example in mass ratio is matched
It is as follows：Radix Angelicae Sinensis, 1 part of radix scutellariae, osmanthus heart, rhizoma zingiberis, each 2 parts of Ligusticum wallichii, gypsum, each 3 parts of almond, 6 parts of jute.
4. a kind of medicine according to claim 1, it is characterised in that the formulation of described medicine can be decoction, pill,
The medically acceptable formulation such as powder, tablet, capsule, granule.
5. a kind of medicine according to claim 1-4, it is characterised in that described medicinal application is in treatment apoplexy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710360144.1A CN107137682A (en) | 2017-05-20 | 2017-05-20 | A kind of Chinese medicine composition for treating apoplexy and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710360144.1A CN107137682A (en) | 2017-05-20 | 2017-05-20 | A kind of Chinese medicine composition for treating apoplexy and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107137682A true CN107137682A (en) | 2017-09-08 |
Family
ID=59778291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710360144.1A Pending CN107137682A (en) | 2017-05-20 | 2017-05-20 | A kind of Chinese medicine composition for treating apoplexy and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107137682A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108187018A (en) * | 2018-03-15 | 2018-06-22 | 天津白大夫健康管理有限公司 | One kind prolongs raw granular recipe |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895632A (en) * | 2011-07-29 | 2013-01-30 | 苏州知微堂生物科技有限公司 | Preparation technology and production method for integrated new formulation of life-prolonging decotion |
-
2017
- 2017-05-20 CN CN201710360144.1A patent/CN107137682A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895632A (en) * | 2011-07-29 | 2013-01-30 | 苏州知微堂生物科技有限公司 | Preparation technology and production method for integrated new formulation of life-prolonging decotion |
Non-Patent Citations (4)
| Title |
|---|
| 吴积海: "脑中风从肺论治", 《河南中医学院学报》 * |
| 周艳艳: "《产科病方剂证治》", 28 February 2014 * |
| 王红: "用大麻治疗中风", 《药物与人》 * |
| 陈立峰: "续命汤颗粒剂治疗中风31例临床观察", 《湖南中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108187018A (en) * | 2018-03-15 | 2018-06-22 | 天津白大夫健康管理有限公司 | One kind prolongs raw granular recipe |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103127232A (en) | Total extract for mulberry leaf prescription as well as preparation and usage thereof | |
| CN100546615C (en) | Be used for the treatment of Chinese medicine composition of cerebrovascular and preparation method thereof | |
| CN103655791B (en) | A kind of lotus leaf-based preparation for treating phlegm and blood stasis simultaneously and application thereof | |
| CN102727548A (en) | New technology and method for extracting ginseng stem and leaf total saponin | |
| CN107137682A (en) | A kind of Chinese medicine composition for treating apoplexy and application | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN102579610A (en) | Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof | |
| CN103372053A (en) | Medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method of medicament | |
| CN102423437B (en) | Double-prescription medicament for treating apoplectic hemiplegia and preparation method thereof | |
| WO2023109362A1 (en) | Method for preparing huoxiangzhengqi soft capsule | |
| CN102335370B (en) | Flavored medicinal composition for removing stasis and dredging collaterals, and preparation method thereof | |
| CN107137683A (en) | A kind of medicine for treating apoplexy and application | |
| CN101618131A (en) | Chinese medicinal compound preparation for treating coronary heart disease and angina | |
| CN103495123B (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
| CN106983849A (en) | A kind of Chinese medicine for treating apoplexy and application | |
| CN101912460B (en) | Preparation method for improving ginsenoside-containing Chinese medicinal extract quality | |
| CN105770487A (en) | Traditional Chinese medicine composition for treating cerebral infarction and cerebral hemorrhage sequelae and preparation method thereof | |
| CN105147994A (en) | Traditional Chinese medicine preparation for treating diabetes and preparation method thereof | |
| CN101569333A (en) | Middle and old aged health protection tea for invigorating kidney | |
| CN1827138A (en) | Chinese medicine composition prescription for treating cardiovascular and cerebrovascular diseases and preparation technique thereof | |
| CN100475248C (en) | A medicine for treating metrorrhagia and preparation process thereof | |
| CN110711235A (en) | Tianshen blood pressure reducing capsule for calming liver, stopping endogenous wind, dredging collaterals, promoting qi circulation, activating blood circulation and removing blood stasis | |
| CN104814994B (en) | A kind of Momordica grosvenori and gynostemma pentaphylla tea beverage | |
| CN107007808A (en) | A kind of medicine for treating apoplexy and its application | |
| CN103585495A (en) | Capsule for treating diabetic kidney damage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170908 |
|
| WD01 | Invention patent application deemed withdrawn after publication |